SEC-sourced researchBeta
MREO
Mereo BioPharma Group plc
Company comparison ↗
Data passport
- CIK
- 0001719714
- Exchange
- Nasdaq
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Mar 19, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 0.0000 | Mar 19, 2026 |
| December 2025 | 500,000.0000 | Mar 19, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 500,000.0000 | -41,878,000.0000 | -30,971,000.0000 | 45,917,000.0000 | 5,001,000.0000 | Mar 19, 2026 |
| December 2024 | 0.0000 | -43,253,000.0000 | -32,834,000.0000 | 76,390,000.0000 | 15,421,000.0000 | Mar 19, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $500K | December 2025 | Mar 19, 2026 | 10-K |
| Previous period revenueRevenues | $0 | December 2024 | Mar 19, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$41.88M | December 2025 | Mar 19, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$30.97M | December 2025 | Mar 19, 2026 | 10-K |
| Total assetsAssets | $45.92M | December 2025 | Mar 19, 2026 | 10-K |
| Total liabilitiesLiabilities | $5M | December 2025 | Mar 19, 2026 | 10-K |